EV/EBITDA:
-14.59+0.20(+1.35%)Summary
- As of today, VKTX EV/EBITDA is -14.59, with a rise of +0.20 (+1.35%) during the most recent trading session on October 16, 2025.
- Over the past year, VKTX EV/EBITDA has increased by +33.36 (+69.57%).
- VKTX EV/EBITDA is now -4268.57% below its all-time high of 0.35.
Performance
VKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VKTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.4% | -1.4% | -1.1% |
| 1M1 Month | -66.9% | +66.8% | +46.6% |
| 3M3 Months | -12.7% | +12.7% | +9.8% |
| 6M6 Months | -39.4% | +72.2% | +47.2% |
| YTDYTD | +38.8% | -13.7% | -13.7% |
| 1Y1 Year | +69.6% | -51.7% | -47.3% |
| 5Y5 Years | -223.5% | +1664.9% | +488.6% |
VKTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -8.42 | -73.3% | -14.79 | +1.4% |
| 3M | 3-Month | -8.42 | -73.3% | -18.48 | +21.1% |
| 6M | 6-Month | -8.42 | -73.3% | -18.48 | +21.1% |
| 1Y | 1-Year | -8.10 | -80.1% | -58.10 | +74.9% |
| 3Y | 3-Year | -1.56 | -835.3% | -95.77 | +84.8% |
| 5Y | 5-Year | 0.35 | -4268.6% | -95.77 | +84.8% |
| All-Time | All-Time | 0.35 | -4268.6% | -95.77 | +84.8% |
VKTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -14.59(+38.8%) |
| 2024 | -23.83(-59.5%) |
| 2023 | -14.94(-80.0%) |
| 2022 | -8.30(-191.2%) |
| Date | Value |
|---|---|
| 2021 | -2.85(+28.2%) |
| 2020 | -3.97(+65.2%) |
| 2018 | -11.42(-893.0%) |
| 2016 | -1.15 |
FAQ
- What is Viking Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
- What is VKTX EV/EBITDA year-to-date change?
- What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Viking Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of VKTX is -14.59
What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high EV/EBITDA is 0.35
What is VKTX EV/EBITDA year-to-date change?
Viking Therapeutics, Inc. EV/EBITDA has changed by +9.24 (+38.77%) since the beginning of the year
What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, VKTX EV/EBITDA has changed by +33.36 (+69.57%)